Coronary artery disease: Clinical sciences

Last updated: January 30, 2025

Coronary artery disease: Clinical sciences

Watch later

Watch later

Parathyroid hormone
Calcitonin
Vitamin D
Insulin
Glucagon
Diabetes mellitus
Diabetes mellitus: Pathology review
Pancreatic neuroendocrine neoplasms
Hyperparathyroidism
Hypoparathyroidism
Parathyroid disorders and calcium imbalance: Pathology review
Insulins
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
Osteoporosis medications
Hypertrophic cardiomyopathy
Pigmentation skin disorders: Pathology review
Albinism
Thymus histology
Glomerular filtration
Measuring renal plasma flow and renal blood flow
Thyroglossal duct cyst
Bowel obstruction
Platelet plug formation (primary hemostasis)
Anatomy of the abdominal viscera: Kidneys, ureters and suprarenal glands
Anatomy of the perineum
Thiazide and thiazide-like diuretics
Vaginal and vulvar disorders: Pathology review
Alpha-thalassemia
Spleen histology
Fallopian tube and uterus histology
Mammary gland histology
Ovary histology
Brucella
Oral cancer
Oxygen binding capacity and oxygen content
Obstructive lung diseases: Pathology review
Ehrlichia and Anaplasma
Myeloproliferative disorders: Pathology review
Nervous system anatomy and physiology
Hyperkalemia
Dementia: Pathology review
Anatomy of the heart
Anatomy of the coronary circulation
Anatomy clinical correlates: Heart
Anatomy clinical correlates: Mediastinum
Infectious endocarditis: Clinical sciences
Infective endocarditis: Clinical
Endocarditis
Endocarditis: Pathology review
Development of the respiratory system
Adenovirus
Anatomy of the arm
Perinatal infections: Clinical
Dyslipidemias: Pathology review
Acyanotic congenital heart defects: Pathology review
Blood pressure, blood flow, and resistance
ECG basics
Development of the cardiovascular system
Fetal circulation
Calcium channel blockers
Anatomy of the eye
Introduction to the cranial nerves
Cranial nerve pathways
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy of the glossopharyngeal nerve (CN IX)
Anatomy of the vagus nerve (CN X)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Actinomyces israelii
Clostridium botulinum (Botulism)
Clostridium tetani (Tetanus)
Haemophilus influenzae
Listeria monocytogenes
Mycobacterium tuberculosis (Tuberculosis)
Neisseria meningitidis
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus agalactiae (Group B Strep)
Streptococcus pneumoniae
Central nervous system histology
Peripheral nervous system histology
Eye and ear histology
Coxsackievirus
Cytomegalovirus
Eastern and Western equine encephalitis virus
Epstein-Barr virus (Infectious mononucleosis)
Herpes simplex virus
JC virus (Progressive multifocal leukoencephalopathy)
Lymphocytic choriomeningitis virus
Measles virus
Mumps virus
Poliovirus
Rabies virus
Varicella zoster virus
West Nile virus
Acute disseminated encephalomyelitis
Central pontine myelinolysis
Multiple sclerosis
Transverse myelitis
Charcot-Marie-Tooth disease
Guillain-Barre syndrome
Adult brain tumors
Neurofibromatosis
Pediatric brain tumors
Pituitary adenoma
Sympathomimetics: Direct agonists
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Cardiac muscle histology
Mesothelioma
Nasal polyps
Nasopharyngeal carcinoma
Pancoast tumor
Superior vena cava syndrome
Cystic fibrosis: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Pneumonia: Pathology review
Tuberculosis: Pathology review
Lung cancer and mesothelioma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Respiratory distress syndrome: Pathology review
Adrenergic antagonists: Presynaptic
Adrenergic receptors
Cholinergic receptors
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympatholytics: Alpha-2 agonists
Introduction to the immune system
Gallbladder disorders: Pathology review
Anatomy of the thyroid and parathyroid glands
Acute coronary syndrome: Clinical sciences
Approach to chest pain: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to hypertension: Clinical sciences
Coronary artery disease: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Dyslipidemia: Clinical sciences
Essential hypertension: Clinical sciences
Tobacco use: Clinical sciences
Ketone body metabolism
Kidney histology
Ureter, bladder and urethra histology
Bladder exstrophy
Horseshoe kidney
Hydronephrosis
Hypospadias and epispadias
Potter sequence
Renal agenesis
Alport syndrome
Goodpasture syndrome
IgA nephropathy (NORD)
Lupus nephritis
Poststreptococcal glomerulonephritis
Rapidly progressive glomerulonephritis
Amyloidosis
Diabetic nephropathy
Focal segmental glomerulosclerosis (NORD)
Membranoproliferative glomerulonephritis
Membranous nephropathy
Minimal change disease
Acute tubular necrosis
Renal papillary necrosis
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Postrenal azotemia
Prerenal azotemia
Renal azotemia
Chronic kidney disease
Kidney stones
Renal tubular acidosis
Angiomyolipoma
Medullary cystic kidney disease
Medullary sponge kidney
Multicystic dysplastic kidney
Polycystic kidney disease
Beckwith-Wiedemann syndrome
Nephroblastoma (Wilms tumor)
Non-urothelial bladder cancers
Renal cell carcinoma
Transitional cell carcinoma
WAGR syndrome
Neurogenic bladder
Posterior urethral valves
Urinary incontinence
Vesicoureteral reflux
Renal artery stenosis
Renal cortical necrosis
Metabolic acidosis
Metabolic alkalosis
Respiratory acidosis
Respiratory alkalosis
Hypercalcemia
Hypermagnesemia
Hypernatremia
Hyperphosphatemia
Hypocalcemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypophosphatemia
Congenital renal disorders: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Urinary tract infections: Pathology review
Kidney stones: Pathology review
Renal failure: Pathology review
Renal tubular acidosis: Pathology review
Renal tubular defects: Pathology review
Renal and urinary tract masses: Pathology review
Urinary incontinence: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Appendicitis
Abdominal hernias
Inguinal hernias: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Ventral and incisional hernias: Clinical sciences
Inguinal hernia
Femoral hernia
Acute pancreatitis: Clinical sciences
Cholecystitis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Anticoagulants: Warfarin
Factor V Leiden

Decision-Making Tree

Transcript

Watch video only

Coronary artery disease, or CAD, is caused by atherosclerosis of the coronary arteries, which occurs when plaque builds up in the vessels, eventually narrowing the lumen, and causing a mismatch between oxygen supply and demand of the heart. Over time, reduced oxygen supply can lead to myocardial ischemia or even infarction.

The diagnosis of CAD is based on atherosclerotic risk factors that categorize patients into low, intermediate, or high risk groups based on their probability for obstructive disease.

Now, if you suspect CAD, first perform an ABCDE assessment. This is to determine if the patient is unstable or stable.

If unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access, provide supplemental oxygen, and put them on continuous vital sign monitoring including blood pressure, heart rate, and pulse oximetry.

At this point, you should suspect CAD with acute coronary syndrome, which includes unstable angina, non-ST elevated myocardial infarction, or NSTEMI, or ST-elevated myocardial infarction, or STEMI.

Once you stabilize the patient, obtain a focused history and physical examination, and order serial troponin levels and an ECG.

Okay, let’s focus on unstable angina, your patient may report sudden chest discomfort that doesn’t improve with rest, and feelings of uneasiness or “impending doom”.

Other common symptoms include dizziness, shortness of breath, sweating, as well as nausea.

Physical exam typically reveals a distressed, anxious, and diaphoretic individual.

Ok, next take a look at the serial troponins. If there’s no myocardial infarction, troponins will typically be normal.

While ECG may or may not show signs of ischemia like ST segment depression or new T wave inversion.

This combination of history, physical exam, labs, and ECG findings are characteristic of unstable angina, where chest pain is caused by an insufficient supply of oxygen to the cardiac tissue.

In these individuals, treatment consists of Morphine, Oxygen, Nitrates, and Aspirin, also known as MONA, as well as a statin and a beta blocker. Additionally, your patient will likely need an invasive coronary angiography with or without revascularization.

Here’s a clinical pearl! A non-ST elevated myocardial infarction, or NSTEMI, can present with similar history, physical exam, and ECG findings as unstable angina, but troponin levels are typically elevated in NSTEMI by definition. However, troponins may initially not be detectable, and may even take hours to rise after presentation, so be sure to keep NSTEMI on your differential even if troponin is normal.

Okay, let’s return to the ABCDE assessment and take a look at stable patients. If your patient is stable, obtain a focused history and physical exam. Your patient will typically describe their chest discomfort or pain as a heavy pressure that is worse with exertion, cold weather, or highly stressful situations, and improves when these conditions subside. Your patient might also report shortness of breath with exertion.

They may also have ASCVD risk factors, such as increasing age, male sex, hypertension, diabetes mellitus, hyperlipidemia, tobacco use, and a family history of premature CAD.

Okay, moving on to the physical exam, you may find elevated blood pressure, decreased peripheral pulses, and bruits, which are all evidence of atherosclerotic disease.

You may also see xanthelasmas, or yellow cholesterol deposits on the eyelids, which indicate underlying hyperlipidemia. Finally, you might detect nicotine-stained fingertips in patients that use tobacco. These findings should make you suspect CAD, particularly stable angina.

Now, here’s a high-yield fact! The key thing that distinguishes stable from unstable angina is that pain improves with rest in stable angina, while pain remains present even at rest with unstable angina. You should also keep in mind that if your patient is a biologically female individual, has a positive history of diabetes mellitus, and reports back or epigastric burning or stabbing pain, you should think of atypical angina!

Now that you suspect CAD, your next step is to order labs.

These include a high-sensitivity troponin, fasting lipid panel, and hemoglobin A1C. Also, you should obtain a 12-lead ECG.

Labs typically reveal troponin levels as normal, lipid panel will reveal an elevated LDL, and hemoglobin A1C elevated too, which is common in patients with poorly controlled diabetes. On the flip side,

ECG could be normal, or show inverted T waves, which is a repolarization abnormality; pathological Q waves, indicating an old myocardial infarction; or a left bundle branch block.

All these findings are highly suggestive of CAD causing stable angina, so your next step is to assess the pretest probability of obstructive CAD. You can do this by using the patient’s age, sex, chest pain symptoms, and risk factors. This allows you to stratify the patient into a low, intermediate, or high risk group and determine the appropriate type of management.

Okay, lets first look at individuals who are at low risk. Patients who are low risk likely have non-obstructive CAD and do not require additional testing. Instead, you should encourage lifestyle modifications, such as a diet rich in fruits, vegetables, whole grains, and fish, as well as 150 minutes of moderate exercise each week, often divided up as 30 minutes 5 times a week, and sleep hygiene. Counsel your patient on tobacco cessation and weight loss, annual influenza vaccines, and mental health.

Sources

  1. "2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines" Circulation (2021)
  2. "2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines" J Am Coll Cardiol (2019)
  3. "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines" J Am Coll Cardiol (2019)
  4. "Harrison's Principles of Internal Medicine, 21e." McGraw Hill (2022)
  5. "I have a patient with chest pain. How do I determine the cause?" McGraw Hill (2020)
  6. "2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" Circulation (2014)
  7. "Heart Disease: Diagnostic Testing" Current Medical Diagnosis & Treatment 2023 (2023)
  8. "Coronary Artery Disease" CDIM Core Medicine Clerkship Curriculum Guide, 4th ed. essay (2020)
  9. "Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement" Am J Prev Cardiol (2022)